D. A. Feshchenko
D. A. Feshchenko has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- F. B. Shukurov
National Medical Research Center for Therapy and Preventive Medicine
38 shared publications - D. K. Vasiliev
National Medical Research Center for Therapy and Preventive Medicine
25 shared publications - B. A. Rudenko
National Medical Research Center for Therapy and Preventive Medicine
19 shared publications - A. S. Shanoyan
National Medical Research Center for Therapy and Preventive Medicine
17 shared publications - M. T. Taliouridze
National Medical Research Center for Therapy and Preventive Medicine
17 shared publications - N. A. Arablinskiy
National Medical Research Center for Therapy and Preventive Medicine
16 shared publications
Latest Publications
- 13 June 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (5)
Myocardial infarction due to spontaneous coronary artery dissection: a retrospective diagnosis. A case report
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is characterized by the absence of stenotic or occlusive lesions in the infarct-related artery on coronary angiography. MINOCA accounts for 6-15% of all MI cases and carries an annual mortality of up to 3,5%. The etiology of this syndrome is heterogeneous and includes atherosclerotic and non-atherosclerotic mechanisms, coronary vasospasm, microvascular dysfunction, thromboembolism, and spontaneous coronary artery dissection (SCAD). SCAD is one of the leading causes of MINOCA in young women and may present with intramural hematoma formation and transient luminal narrowing, often requiring intravascular imaging for an accurate diagnosis. This article describes a case of MINOCA caused by SCAD in a 34-year-old female patient, confirmed by comprehensive laboratory and imaging evaluation including intravascular techniques.
- 13 June 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (5)
Myocardial infarction due to spontaneous coronary artery dissection: a retrospective diagnosis. A case report
Myocardial infarction with non-obstructive coronary arteries (MINOCA) is characterized by the absence of stenotic or occlusive lesions in the infarct-related artery on coronary angiography. MINOCA accounts for 6-15% of all MI cases and carries an annual mortality of up to 3,5%. The etiology of this syndrome is heterogeneous and includes atherosclerotic and non-atherosclerotic mechanisms, coronary vasospasm, microvascular dysfunction, thromboembolism, and spontaneous coronary artery dissection (SCAD). SCAD is one of the leading causes of MINOCA in young women and may present with intramural hematoma formation and transient luminal narrowing, often requiring intravascular imaging for an accurate diagnosis. This article describes a case of MINOCA caused by SCAD in a 34-year-old female patient, confirmed by comprehensive laboratory and imaging evaluation including intravascular techniques.
- Open Access
- 14 March 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (2) , 4671
Role of intraoperative intravascular ultrasound in the prevention of periprocedural complications during internal carotid artery stenting. A case report
Carotid angioplasty with stenting (CAS) is an alternative to surgery in patients with high surgical risk after carotid endarectomy. According to the large randomized controlled trial Carotid Revascularization Endart-erectomy versus Stenting (CREST), there are no significant differences in the rates of stroke, myocardial infarction, or death in the long-term follow-up between the CAS and carotid endarectomy groups. However,a significant number of complications in the CAS group are associated with the periprocedural period. The safety of CAS directly depends on the technical success of the procedure and minimizing the risk of cerebral embolism. Despite the use of embolic protection in 100% of cases, stroke prevention remains a pressing issue. A clinical case demonstrates the impact of intraoperative intravascular ultrasound (IVUS) on interventional tactics and complication prevention in CAS, and an algorithm for managing intraprocedural plaque protrusion is proposed. This case confirms that IVUS is not simply a diagnostic tool, but a strategic tool that enables individualized treatment at all CAS stages. Routine use of IVUS for plaque morphology assessment, intraoperative monitoring, and complication management can significantly improve procedural safety. A management algorithm for patients with plaque protrusion is proposed.
- 14 March 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (2) , 4671
Open AccessRole of intraoperative intravascular ultrasound in the prevention of periprocedural complications during internal carotid artery stenting. A case report
Carotid angioplasty with stenting (CAS) is an alternative to surgery in patients with high surgical risk after carotid endarectomy. According to the large randomized controlled trial Carotid Revascularization Endart-erectomy versus Stenting (CREST), there are no significant differences in the rates of stroke, myocardial infarction, or death in the long-term follow-up between the CAS and carotid endarectomy groups. However,a significant number of complications in the CAS group are associated with the periprocedural period. The safety of CAS directly depends on the technical success of the procedure and minimizing the risk of cerebral embolism. Despite the use of embolic protection in 100% of cases, stroke prevention remains a pressing issue. A clinical case demonstrates the impact of intraoperative intravascular ultrasound (IVUS) on interventional tactics and complication prevention in CAS, and an algorithm for managing intraprocedural plaque protrusion is proposed. This case confirms that IVUS is not simply a diagnostic tool, but a strategic tool that enables individualized treatment at all CAS stages. Routine use of IVUS for plaque morphology assessment, intraoperative monitoring, and complication management can significantly improve procedural safety. A management algorithm for patients with plaque protrusion is proposed.
- Open Access
- 14 March 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (2) , 4682
Impact of carotid stenting on blood pressure in patients with ipsilateral stenosis: clinical and hemodynamic predictors and their prognostic value
Aim. To determine clinical, anatomical, and intraoperative predictors of sustained blood pressure (BP) reduction in patients with ipsilateral internal carotid artery stenosis after carotid artery stenting (CAS). Material and methods. This single-center prospective study included 178 patients who underwent CAS between 2018 and 2022. All patients underwent clinical BP measurements and ambulatory 24-hour BP monitoring (ABPM) before the [procedure and after 12 months. A sustained hypotensive response was defined as a reduction in average 24-hour systolic/diastolic BP ≥10/5 mm Hg, as measured by ABPM. Anatomical (stenosis degree, plaque morphology, circle of Willis structure, etc.), anthropometric and clinical parameters (age, sex, comorbidities, etc.), as well as intraoperative factors (hypotension, bradycardia, dilation, etc.) were studied. Results. At baseline, hypertension was detected in 98,6% of patients, while target BP values were achieved in only 28,4%. A significant decrease in office BP was observed as early as 24 hours after CAS (systolic BP 157®114 mm Hg, diastolic BP 87®64 mm Hg; pConclusion. A persistent BP reduction after CAS was observed in almost half of patients with ipsilateral internal carotid artery stenosis. The severity of the hypotensive response is determined by cerebral circulation anatomy (disconnected structure of the circle of Willis), stenosis degree, and intraoperative reactions of the carotid sinus. These factors can be used to predict the hemodynamic response and optimize patient management after CAS.
- 14 March 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 25 (2) , 4682
Open AccessImpact of carotid stenting on blood pressure in patients with ipsilateral stenosis: clinical and hemodynamic predictors and their prognostic value
Aim. To determine clinical, anatomical, and intraoperative predictors of sustained blood pressure (BP) reduction in patients with ipsilateral internal carotid artery stenosis after carotid artery stenting (CAS). Material and methods. This single-center prospective study included 178 patients who underwent CAS between 2018 and 2022. All patients underwent clinical BP measurements and ambulatory 24-hour BP monitoring (ABPM) before the [procedure and after 12 months. A sustained hypotensive response was defined as a reduction in average 24-hour systolic/diastolic BP ≥10/5 mm Hg, as measured by ABPM. Anatomical (stenosis degree, plaque morphology, circle of Willis structure, etc.), anthropometric and clinical parameters (age, sex, comorbidities, etc.), as well as intraoperative factors (hypotension, bradycardia, dilation, etc.) were studied. Results. At baseline, hypertension was detected in 98,6% of patients, while target BP values were achieved in only 28,4%. A significant decrease in office BP was observed as early as 24 hours after CAS (systolic BP 157®114 mm Hg, diastolic BP 87®64 mm Hg; pConclusion. A persistent BP reduction after CAS was observed in almost half of patients with ipsilateral internal carotid artery stenosis. The severity of the hypotensive response is determined by cerebral circulation anatomy (disconnected structure of the circle of Willis), stenosis degree, and intraoperative reactions of the carotid sinus. These factors can be used to predict the hemodynamic response and optimize patient management after CAS.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- Open Access
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4604
Predictors of unfavorable long-term outcomes of internal carotid artery stenting
Aim. To identify factors influencing the clinical outcomes of endovascular treatment of patients with hemodynamically significant internal carotid artery (ICA) disease in the long-term postoperative period. Material and methods. From February 2013 to January 2022, carotid stenting was performed in 288 patients (223 men, 65 women) aged 4086 years for hemodynamically significant ICA disease at the National Medical Research Center for Therapy and Preventive. The retrospective part analyzed patient records (n=110), while the prospective part included 178 patients. During the 12-month postoperative follow-up, the incidence of cerebrovascular events (transient ischemic attacks, minor and major strokes, transient monocular blindness, acute myocardial infarction, all-cause mortality, restenosis in the stenting area, and the need for reinterventions) was monitored. To identify significant prognostic factors, the relationship between long-term clinical outcomes and the following groups of parameters was analyzed: morphological stenosis characteristics, patient clinical and anamnestic data (age, comorbidities), and technical features of the endovascular intervention. Results. Multivariate analysis identified predictors of the composite endpoint (death + myocardial infarction + stroke + transient ischemic attack + repeat revascularization). Among clinical factors, obesity demonstrated independent prognostic value, with a hazard ratio (HR) of 1,89 (95% confidence interval (CI): 1,28-4,73, p=0,042). The anatomical and morphological characteristics of the lesion had the greatest impact on the incidence of events: complicated plaque (ulceration, thrombosis, or hemorrhage) — HR 3,47 (95% CI: 1,258,68, p=0,029); stenosis length ≥15 mm — HR 2,12 (95% CI: 1,414,03, p=0,032). Technical aspects of the intervention were of great importance — residual stenosis in the range of 10-30% — HR 2,38 (95% CI: 1,38-3,48, p=0,011). Conclusion. The obtained data emphasize the need for a thorough assessment of the lesion morphology and achieving an optimal angiographic data during carotid artery stenting, especially in obese patients with extensive stenoses. The identified risk factors can be used to stratify patients and develop personalized approaches to postoperative follow-up.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4604
Open AccessPredictors of unfavorable long-term outcomes of internal carotid artery stenting
Aim. To identify factors influencing the clinical outcomes of endovascular treatment of patients with hemodynamically significant internal carotid artery (ICA) disease in the long-term postoperative period. Material and methods. From February 2013 to January 2022, carotid stenting was performed in 288 patients (223 men, 65 women) aged 4086 years for hemodynamically significant ICA disease at the National Medical Research Center for Therapy and Preventive. The retrospective part analyzed patient records (n=110), while the prospective part included 178 patients. During the 12-month postoperative follow-up, the incidence of cerebrovascular events (transient ischemic attacks, minor and major strokes, transient monocular blindness, acute myocardial infarction, all-cause mortality, restenosis in the stenting area, and the need for reinterventions) was monitored. To identify significant prognostic factors, the relationship between long-term clinical outcomes and the following groups of parameters was analyzed: morphological stenosis characteristics, patient clinical and anamnestic data (age, comorbidities), and technical features of the endovascular intervention. Results. Multivariate analysis identified predictors of the composite endpoint (death + myocardial infarction + stroke + transient ischemic attack + repeat revascularization). Among clinical factors, obesity demonstrated independent prognostic value, with a hazard ratio (HR) of 1,89 (95% confidence interval (CI): 1,28-4,73, p=0,042). The anatomical and morphological characteristics of the lesion had the greatest impact on the incidence of events: complicated plaque (ulceration, thrombosis, or hemorrhage) — HR 3,47 (95% CI: 1,258,68, p=0,029); stenosis length ≥15 mm — HR 2,12 (95% CI: 1,414,03, p=0,032). Technical aspects of the intervention were of great importance — residual stenosis in the range of 10-30% — HR 2,38 (95% CI: 1,38-3,48, p=0,011). Conclusion. The obtained data emphasize the need for a thorough assessment of the lesion morphology and achieving an optimal angiographic data during carotid artery stenting, especially in obese patients with extensive stenoses. The identified risk factors can be used to stratify patients and develop personalized approaches to postoperative follow-up.
- Open Access
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4582
Carotid artery stenting: state of the art
In most developed countries, cerebrovascular accident (CVA) ranks second or third in mortality and is the leading cause of disability in adults. Ischemic stroke accounts for 70-90% of all cases of CVAs. Internal carotid artery (ICA) atherosclerosis with stenosis >50% account for 9-40% of ischemic strokes. Pharmacotherapy is the first-line treatment for patients with ICA atherosclerosis. However, some studies suggest that pharmacotherapy is ineffective in patients at high CVA risk. According to current Russian guidelines, carotid endarterectomy is the procedure of choice for patients with significant stenosis of the ICA. However, with the advances of endovascular technologies, carotid angioplasty with stenting has become an alternative revascularization option. According to the 10-year Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), the predominant difference in cerebral ischemic events after carotid angioplasty with stenting versus carotid endarterectomy occurred in the periprocedural period. However, after successful surgery, the late-term complication rates in the stenting group and the open surgery group were comparable. Thus, proper preoperative preparation of patients for ICA stenting and periprocedural management are key to improving the outcomes of endovascular intervention.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12) , 4582
Open AccessCarotid artery stenting: state of the art
In most developed countries, cerebrovascular accident (CVA) ranks second or third in mortality and is the leading cause of disability in adults. Ischemic stroke accounts for 70-90% of all cases of CVAs. Internal carotid artery (ICA) atherosclerosis with stenosis >50% account for 9-40% of ischemic strokes. Pharmacotherapy is the first-line treatment for patients with ICA atherosclerosis. However, some studies suggest that pharmacotherapy is ineffective in patients at high CVA risk. According to current Russian guidelines, carotid endarterectomy is the procedure of choice for patients with significant stenosis of the ICA. However, with the advances of endovascular technologies, carotid angioplasty with stenting has become an alternative revascularization option. According to the 10-year Carotid Revascularization Endarterectomy versus Stenting Trial (CREST), the predominant difference in cerebral ischemic events after carotid angioplasty with stenting versus carotid endarterectomy occurred in the periprocedural period. However, after successful surgery, the late-term complication rates in the stenting group and the open surgery group were comparable. Thus, proper preoperative preparation of patients for ICA stenting and periprocedural management are key to improving the outcomes of endovascular intervention.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- 8 February 2026
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (12)
Endovascular treatment of post-thrombotic ileocaval-femoral venous obstruction. A case report
According to widely published data, intravascular imaging (IVI)-guided endovascular venous stenting is an effective and safe alternative to open reconstructive surgery of the iliofemoral venous segment. Data on the potential of endovascular treatments for the ileocaval segment are currently insufficient. However, for some patients, this minimally invasive reconstructive surgery may be a viable alternative to open surgery. This article presents the case of a 48-year-old patient with severe postthrombotic disease, severe venous claudication, bilateral ileofemoral obstruction, and extensive occlusion of the infrarenal part of the inferior vena cava. Single-step endovascular IVI-guided recanalization and reconstruction of the ileocaval-femoral segment was performed with implantation of Abre™ and Wallstent™ venous stents. After 6 months, we revealed a decrease in venous hypertension symptoms, an increase in walking distance, a decrease in postthrombotic syndrome severity according to Villalta score, and an improvement in the Venous Clinical Severity Score.
- Open Access
- 17 August 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (7) , 4461
Endovascular myocardial revascularization in a patient after transcatheter aortic valve implantation: a case report
Transcatheter aortic valve implantation (TAVI) is an effective and safe method for treating aortic stenosis (AS), especially in patients at high surgical risk. With the improvement of the quality and increase in life expectancy of the population, comorbid patients with critical AS will increasingly be encountered in practice, for whom TAVI will be the main method of surgical treatment. Despite the achieved successes in the management of patients with cardiovascular diseases, their cotinuous progression can lead to de novo atherosclerotic lesions or restenosis in the previously stented coronary segment. The design of prosthetic aortic valves used in TAVI can impose a number of technical limitations when repeated coronary interventions are necessary. This article presents a case of successful endovascular treatment of multivessel coronary artery disease guided by intravascular coronary flow assessment in a comorbid patient after TAVI.
- 17 August 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (7) , 4461
Open AccessEndovascular myocardial revascularization in a patient after transcatheter aortic valve implantation: a case report
Transcatheter aortic valve implantation (TAVI) is an effective and safe method for treating aortic stenosis (AS), especially in patients at high surgical risk. With the improvement of the quality and increase in life expectancy of the population, comorbid patients with critical AS will increasingly be encountered in practice, for whom TAVI will be the main method of surgical treatment. Despite the achieved successes in the management of patients with cardiovascular diseases, their cotinuous progression can lead to de novo atherosclerotic lesions or restenosis in the previously stented coronary segment. The design of prosthetic aortic valves used in TAVI can impose a number of technical limitations when repeated coronary interventions are necessary. This article presents a case of successful endovascular treatment of multivessel coronary artery disease guided by intravascular coronary flow assessment in a comorbid patient after TAVI.
- Open Access
- 20 April 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (3) , 4326
Efficacy and safety of renal denervation in comorbid patients with resistant hypertension: results of a two-year follow-up
Aim. To study the clinical efficacy of renal denervation (RDN) in patients with resistant hypertension (RH), type 2 diabetes (T2D) and coronary artery disease (CAD) after endovascular revascularization.Material and methods. The prospective, non-randomized, controlled, single-center study included 75 patients with true RH, T2D and CAD after complete endovascular revascularization. The participants were distributed in a 1:1,5 ratio into the RDN group and the control group. RDN was performed through femoral vascular access with a Spyral catheter (Medtronic, USA). The follow-up period was 24 months. The primary endpoint was the change in mean 24-hour arterial pressure (BP). The secondary endpoint was the assessment of the incidence of adverse cardiovascular and cerebral events. Changes in paraclinical parameters and drug therapy were also assessed.Results. In the RDN group, mean 24-hour systolic BP decreased from 158 [144;167] to 147 [137;156] mm Hg (pde novo stenosis was 23,3% in the RDN group and 22,2% in the control group. There were no differences between the groups. The glomerular filtration rate in both groups did not change significantly and remained stable.Conclusion. The study results confirm the favorable pleiotropic effects and safety of RDN in polymorbid patients with a combination of RH, T2D and CAD with the total sympathetic nervous system involvement, which offers opportunities for a wider study and implementation of this interventional procedure in clinical practice.
- 20 April 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 24 (3) , 4326
Open AccessEfficacy and safety of renal denervation in comorbid patients with resistant hypertension: results of a two-year follow-up
Aim. To study the clinical efficacy of renal denervation (RDN) in patients with resistant hypertension (RH), type 2 diabetes (T2D) and coronary artery disease (CAD) after endovascular revascularization.Material and methods. The prospective, non-randomized, controlled, single-center study included 75 patients with true RH, T2D and CAD after complete endovascular revascularization. The participants were distributed in a 1:1,5 ratio into the RDN group and the control group. RDN was performed through femoral vascular access with a Spyral catheter (Medtronic, USA). The follow-up period was 24 months. The primary endpoint was the change in mean 24-hour arterial pressure (BP). The secondary endpoint was the assessment of the incidence of adverse cardiovascular and cerebral events. Changes in paraclinical parameters and drug therapy were also assessed.Results. In the RDN group, mean 24-hour systolic BP decreased from 158 [144;167] to 147 [137;156] mm Hg (pde novo stenosis was 23,3% in the RDN group and 22,2% in the control group. There were no differences between the groups. The glomerular filtration rate in both groups did not change significantly and remained stable.Conclusion. The study results confirm the favorable pleiotropic effects and safety of RDN in polymorbid patients with a combination of RH, T2D and CAD with the total sympathetic nervous system involvement, which offers opportunities for a wider study and implementation of this interventional procedure in clinical practice.
- Open Access
- 12 February 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (12) , 4210
Effect of renal denervation on blood biomarker levels in patients with resistant hypertension, diabetes and coronary artery disease after 12-month follow-up
Aim. To study the effects of catheter renal denervation (RDN) on blood biomarker levels in patients with cardiovascular comorbidity and type 2 diabetes (T2D). Material and methods. Sixty patients with true resistant hypertension (HTN) in combination with T2D and coronary artery disease after complete myocardial revascularization using percutaneous coronary intervention were included in a prospective observational non-randomized study. Patients were distributed in a 1:1 ratio into the intervention group and the control group. RDN was performed through femoral access using a Spyral system (Medtronic, USA). The primary endpoint was the change in plasma renin activity after 12 months. The results are presented as Me (Q25; Q75). Results. In the intervention group, plasma renin activity significantly decreased from 4,65 (1,88; 7,79) to 2,21 (0,87; 5,49) ng/ml/h; angiotensin-I from 1,73 (0,34; 3,22) to 0,46 (0,31; 1,95) ng/ml; aldosterone from 131 (78; 173) to 118 (68; 153) pg/ml (p6,5 ng/ml/h). The blood pressure decreases correlated with decrease in plasma renin activity (r=0,85; pConclusion. The use of RDN in comorbid patients is safe and allows for better control of modifiable risk factors for the progression of HTN and T2D due to an improvement of blood pressure, carbohydrate metabolism parameters, regulatory factors of the renin-angiotensin-aldosterone system, and factors of the systemic inflammatory response.
- 12 February 2025
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 23 (12) , 4210
Open AccessEffect of renal denervation on blood biomarker levels in patients with resistant hypertension, diabetes and coronary artery disease after 12-month follow-up
Aim. To study the effects of catheter renal denervation (RDN) on blood biomarker levels in patients with cardiovascular comorbidity and type 2 diabetes (T2D). Material and methods. Sixty patients with true resistant hypertension (HTN) in combination with T2D and coronary artery disease after complete myocardial revascularization using percutaneous coronary intervention were included in a prospective observational non-randomized study. Patients were distributed in a 1:1 ratio into the intervention group and the control group. RDN was performed through femoral access using a Spyral system (Medtronic, USA). The primary endpoint was the change in plasma renin activity after 12 months. The results are presented as Me (Q25; Q75). Results. In the intervention group, plasma renin activity significantly decreased from 4,65 (1,88; 7,79) to 2,21 (0,87; 5,49) ng/ml/h; angiotensin-I from 1,73 (0,34; 3,22) to 0,46 (0,31; 1,95) ng/ml; aldosterone from 131 (78; 173) to 118 (68; 153) pg/ml (p6,5 ng/ml/h). The blood pressure decreases correlated with decrease in plasma renin activity (r=0,85; pConclusion. The use of RDN in comorbid patients is safe and allows for better control of modifiable risk factors for the progression of HTN and T2D due to an improvement of blood pressure, carbohydrate metabolism parameters, regulatory factors of the renin-angiotensin-aldosterone system, and factors of the systemic inflammatory response.